⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Data 3 from Uncoupling CD4⁺ TIL-mediated tumor killing from JAK-signaling in melanoma

Arianna Draghi Mario Presti Agnete W.P. Jensen Christopher A. Chamberlain Benedetta Albieri Anne-Christine K. Rasmussen Mads Hald Andersen Michael D. Crowther Inge Marie Svane Marco Donia

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

CD4+ TILs can exert cytotoxicity against JAK1KO MHCIIConst+ tumors even in absence of IFNγ stimulation (TCL#17)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Draghi et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587523006 https://doi.org/10.1158/1078-0432.27031375

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
2Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
3Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
4Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
5Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024

Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
Data from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024